T2 Biosystems Announces the Initiation of the T2Resistance® Panel Clinical Trial Read more about T2 Biosystems Announces the Initiation of the T2Resistance® Panel Clinical Trial
T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant Read more about T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant
T2 Biosystems Announces Continued International Expansion into Taiwan with Exclusive Distribution Agreement Read more about T2 Biosystems Announces Continued International Expansion into Taiwan with Exclusive Distribution Agreement
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum Read more about T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
T2 Biosystems Participates in the World Anti-Microbial Resistance Congress Read more about T2 Biosystems Participates in the World Anti-Microbial Resistance Congress
T2 Biosystems Hires Industry Veteran Brett Giffin as Chief Commercial Officer Read more about T2 Biosystems Hires Industry Veteran Brett Giffin as Chief Commercial Officer
T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021 Read more about T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021
T2 Biosystems Announces Distribution Agreements in Key Asia-Pacific Markets Read more about T2 Biosystems Announces Distribution Agreements in Key Asia-Pacific Markets
T2 Biosystems Appoints Laura Adams to Its Board of Directors Read more about T2 Biosystems Appoints Laura Adams to Its Board of Directors
T2 Biosystems Reports Granting of Inducement Award Read more about T2 Biosystems Reports Granting of Inducement Award
